NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
企業コードNBY
会社名NovaBay Pharmaceuticals Inc
上場日Oct 26, 2007
最高経営責任者「CEO」Mr. Justin M. Hall, Esq.
従業員数14
証券種類Ordinary Share
決算期末Oct 26
本社所在地2000 Powell St Ste 1150
都市EMERYVILLE
証券取引所NYSE American Consolidated
国United States of America
郵便番号94608-1804
電話番号15108998800
ウェブサイトhttps://novabay.com/
企業コードNBY
上場日Oct 26, 2007
最高経営責任者「CEO」Mr. Justin M. Hall, Esq.
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし